Get the Stockscreener App
0.80
2.75%
-0.00
Trinity Biotech Plc Adr stock is traded at $0.80, with a volume of 195.07K.
It is down -2.75% in the last 24 hours and down -17.67% over the past month.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
See More
Previous Close:
$0.80
Open:
$0.8
24h Volume:
195.07K
Relative Volume:
0.10
Market Cap:
$22.02M
Revenue:
$71.39M
Net Income/Loss:
$-28.60M
P/E Ratio:
-0.2139
EPS:
-3.74
Net Cash Flow:
$-12.92M
1W Performance:
-13.56%
1M Performance:
-17.67%
6M Performance:
-71.81%
1Y Performance:
-70.13%
1-Day Range:
$0.77
$0.81
1-Week Range:
$0.77
$0.9909
52-Week Range:
$0.74
$3.55
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
Name
Trinity Biotech Plc Adr
Sector
Industry
Phone
-
Address
-
Compare TRIB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
0.79 | 22.02M | 71.39M | -28.60M | -12.92M | -3.74 |
|
ABT
Abbott Laboratories
|
129.01 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.39 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
391.51 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.73 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.88 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-15 | Downgrade | Craig Hallum | Buy → Hold |
| Sep-03-15 | Initiated | Raymond James | Outperform |
| Jul-29-15 | Reiterated | ROTH Capital | Buy |
| Jul-22-08 | Reiterated | Roth Capital | Buy |
| Mar-17-08 | Reiterated | Roth Capital | Buy |
| Dec-10-07 | Reiterated | Roth Capital | Buy |
| Oct-26-07 | Reiterated | Roth Capital | Buy |
View All
Trinity Biotech Plc Adr Stock (TRIB) Latest News
Trinity Biotech Plc ADR (TRIB) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Market Highlights: Xometry Inc (XMTR) Ends on a Low Note at 36.21 - The Dwinnex
Daily Progress: SiTime Corp (SITM) Drop -20.93, Closing at 176.32 - The Dwinnex
Trinity Biotech Plc ADR (TRIB) Shares Down Despite Recent Market Volatility - The News Heater
Trinity Biotech reports leap in CGM system accuracy - Investing.com
Trinity Biotech secures US funding for HIV tests - Investing.com
Trinity Biotech faces US aid policy impact, PPP loan scrutiny - Investing.com India
Trinity Biotech announces breakthrough in CGM technology - Investing.com India
Trinity Biotech stock hits 52-week low at $0.74 amid challenges By Investing.com - Investing.com South Africa
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
Hemoglobin A1c (HbA1c) Testing Market Projected to Reach $1.83 Billion by 2024, Growth Fueled by Rising Prevalence of Diabetes - GlobeNewswire Inc.
Trinity Biotech revises credit terms to boost liquidity - Investing.com India
Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan - GlobeNewswire Inc.
Trinity Biotech advances HIV test manufacturing to offshore site - Investing.com
Trinity Biotech files to sell 0.65M American Depositary shares by selling shareholders - MSN
Earnings call: Trinity Biotech Q3 2024 shows steady growth, strategic moves - Investing.com
What to look for when Lowe’s (LOW) reports Q3 2024 earnings results - AlphaStreet
Trinity Biotech regains Nasdaq compliance - Investing.com India
TRIBTrinity Biotech plc Latest Stock News & Market Updates - StockTitan
Trinity Biotech expands into oncology with EpiCapture buyout - Investing.com
Trinity Biotech invests in rapid sepsis diagnostics firm By Investing.com - Investing.com
Trinity Biotech advances next-gen glucose monitor - Investing.com
Trinity Biotech acquires Metabolomics Diagnostics - Investing.com
TRIB underperforms with a -14.67 decrease in share price - US Post News
Balance Sheet Breakdown: Trinity Biotech Plc ADR (TRIB)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Trinity Biotech to launch CGM tech in India, seeks feedback - Investing.com India
North America Blood Testing Market Size & Outlook, 2030 - Grand View Research
Middle East & Africa Blood Testing Market Size & Outlook, 2030 - Grand View Research
Asia Pacific Blood Testing Market Size & Outlook, 2030 - Grand View Research
India Blood Testing Market Size & Outlook, 2023-2030 - Grand View Research
Germany Blood Testing Market Size & Outlook, 2023-2030 - Grand View Research
Latin America Blood Testing Market Size & Outlook, 2030 - Grand View Research
The United States Blood Testing Market Size & Outlook, 2030 - Grand View Research
Indonesia Blood Testing Market Size & Outlook, 2023-2030 - Grand View Research
UK Blood Testing Market Size & Outlook, 2023-2030 - Grand View Research
Trinity Biotech names new Chief Commercial Officer - Investing.com
It is Poised to be a Bull Market for Trinity Biotech Plc ADR (TRIB) - SETE News
Market Recap: Trinity Biotech Plc ADR (TRIB)’s financial ratios: A comprehensive overview - The Dwinnex
Examining Trinity Biotech Plc ADR (TRIB) stock is warranted - US Post News
Trinity Biotech Plc ADR (TRIB) is looking forward to a strong quarter - SETE News
A Tale of Resilience: Trinity Biotech Plc ADR Amid Stock Market Turbulence - The InvestChronicle
Ratios Reveal: Breaking Down Trinity Biotech Plc ADR (TRIB)’s Financial Health - The Dwinnex
Martin Shkreli ordered to give up all copies of one-of-a-kind Wu-Tang Clan album - CNN
Trinity Biotech raises 2024 sales forecast for HIV test - Investing.com India
Li Auto Inc. Sponsored ADR (LI) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Trinity Biotech appoints new biosensor marketing director - Investing.com India
Why PDD Holdings Inc. Sponsored ADR (PDD) Outpaced the Stock Market Today - Yahoo Finance
XPeng Inc. Sponsored ADR (XPEV) Laps the Stock Market: Here's Why - Yahoo Finance
Contrast Security Application Detection and Response (ADR) Praised by Industry Analysts for Addressing Gap in Cybersecurity Defenses - Yahoo Finance
Trinity Biotech gets extension to meet Nasdaq listing rules - Investing.com India
Li Auto Inc. Sponsored ADR (LI) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Trinity Biotech Plc Adr Stock (TRIB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):